HLA-A and nasopharyngeal carcinoma: By using our strep-tagged HLA overexpressing on EBV-positive nasopharyngeal carcinoma cells, we yielded thirteen EBV peptides presented on HLA-A*11:01, HLA-A*02:01 and assessed their immunogenicity in EBV-positive donors.